Antivirals

2025-09-29 🇷🇴 Română

What is it?

Antivirals encompass a class of medications specifically designed to treat viral infections affecting the skin and mucous membranes. These agents work by interfering with viral replication cycles, preventing the virus from multiplying and spreading to healthy cells. Available in both topical and systemic formulations, antivirals include nucleoside analogues (acyclovir, valacyclovir) that mimic viral DNA building blocks, effectively halting viral reproduction. While not curative for chronic viral infections like herpes simplex, antivirals significantly reduce outbreak severity, duration, and transmission risk, representing essential therapy for managing cutaneous viral manifestations.

What are the indications?

Antivirals demonstrate therapeutic efficacy against various cutaneous viral infections:

  • Main indications:
    • Herpes simplex virus infections (oral and genital herpes) - treating active outbreaks and suppression therapy
    • Herpes zoster (shingles) - reducing pain, duration, and post-herpetic neuralgia risk
    • Varicella (chickenpox) - decreasing severity and complications in high-risk patients
  • Secondary indications:
    • Eczema herpeticum - widespread herpes infection in atopic dermatitis patients
    • Cytomegalovirus infections in immunocompromised patients
    • Prophylaxis in immunosuppressed individuals undergoing procedures

How does it work?

Antivirals interrupt viral replication through targeted molecular mechanisms:

  • Primary mechanism: Incorporation into viral DNA chains as false nucleotides, causing premature chain termination and preventing completion of viral genome replication, specifically targeting viral DNA polymerase with minimal effect on human cells
  • Therapeutic effect: Reduction in viral shedding, accelerated healing of lesions, decreased pain and systemic symptoms, and prevention of viral spread to adjacent tissues or transmission to others
  • Onset of action: Most effective when initiated within 48-72 hours of symptom onset, with clinical improvement typically observed within 24-48 hours for acute infections

How is it used?

Antiviral therapy protocols vary based on indication and formulation:

  • Method of administration:
    • Topical: Apply thin layer to affected areas 5 times daily during waking hours
    • Oral: Take with full glass of water with or without food to maintain hydration
  • Typical dosing schedule:
    • Acute treatment: 5-10 days for initial outbreaks, 3-5 days for recurrences
    • Suppressive therapy: Daily low-dose administration for frequent recurrences (>6 yearly)
  • Duration of treatment: Varies from 5 days for simple infections to indefinite suppression in immunocompromised patients
  • What to expect: Pain reduction within 24-48 hours, cessation of new lesion formation by day 3, complete healing within 7-10 days for most infections

What are the adverse reactions?

Antivirals generally demonstrate good tolerability with route-dependent adverse effects:

  • Common reactions (topical formulations):
    • Local irritation including burning, stinging, or mild erythema at application site
    • Dry, flaky skin with prolonged topical use
    • Contact dermatitis in sensitive individuals
  • Common reactions (systemic formulations):
    • Gastrointestinal symptoms (nausea, diarrhea, abdominal pain)
    • Headache and dizziness
    • Fatigue and malaise during treatment
  • Serious reactions (rare with appropriate dosing):
    • Acute kidney injury with high doses or pre-existing renal impairment
    • Neurological symptoms (confusion, hallucinations) particularly in elderly
    • Thrombotic thrombocytopenic purpura (extremely rare)

Who should not use it?

Antivirals require careful consideration in specific patient populations:

  • Absolute contraindications:
    • Known hypersensitivity to the specific antiviral agent or its components
    • Severe renal impairment without appropriate dose adjustment (systemic agents)
  • Relative contraindications:
    • Concurrent nephrotoxic medications requiring enhanced monitoring
    • Neurological disorders (may increase risk of CNS side effects)
  • Special precautions:
    • Pregnancy and breastfeeding: acyclovir is considered safe in pregnancy (FDA Category B), but use only when benefit justifies potential risk; valacyclovir and famciclovir have more limited data
    • Elderly patients require dose adjustment based on renal function
    • Immunocompromised patients may require higher doses or longer treatment duration

Tips for getting the most out of treatment

Maximizing therapeutic benefits:

  • Initiate treatment at first prodromal symptoms (tingling, burning) before visible lesions appear
  • Complete full treatment course even if symptoms improve to prevent recurrence
  • Combine systemic therapy with topical analgesics for optimal symptom relief

Minimizing adverse reactions:

  • Maintain adequate hydration (2-3 liters daily) during systemic therapy to prevent renal complications
  • Take oral medications with food to reduce gastrointestinal symptoms
  • Apply topical preparations with cotton swab to prevent spread and contamination

Lifestyle considerations:

  • Avoid sexual contact during active genital herpes outbreaks even with treatment
  • Practice strict hand hygiene to prevent viral spread to other body sites or individuals
  • Consider suppressive therapy if experiencing frequent recurrences impacting quality of life